These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 31045659)
21. Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review. Pluquet M; Kamel S; Choukroun G; Liabeuf S; Laville SM Toxins (Basel); 2022 Sep; 14(9):. PubMed ID: 36136575 [TBL] [Abstract][Full Text] [Related]
22. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Salem S; Bruck H; Bahlmann FH; Peter M; Passlick-Deetjen J; Kretschmer A; Steppan S; Volsek M; Kribben A; Nierhaus M; Jankowski V; Zidek W; Jankowski J Am J Nephrol; 2012; 35(1):31-9. PubMed ID: 22179063 [TBL] [Abstract][Full Text] [Related]
23. Serum calcification propensity predicts all-cause mortality in predialysis CKD. Smith ER; Ford ML; Tomlinson LA; Bodenham E; McMahon LP; Farese S; Rajkumar C; Holt SG; Pasch A J Am Soc Nephrol; 2014 Feb; 25(2):339-48. PubMed ID: 24179171 [TBL] [Abstract][Full Text] [Related]
24. Magnesium as a Calcification Inhibitor. Hénaut L; Massy ZA Adv Chronic Kidney Dis; 2018 May; 25(3):281-290. PubMed ID: 29793668 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms of Vascular Calcification in Kidney Disease. Disthabanchong S; Srisuwarn P Adv Chronic Kidney Dis; 2019 Nov; 26(6):417-426. PubMed ID: 31831120 [TBL] [Abstract][Full Text] [Related]
26. Daily variability in serum levels of calciprotein particles and their association with mineral metabolism parameters: A cross-sectional pilot study. Yamada H; Kuro-O M; Ishikawa SE; Funazaki S; Kusaka I; Kakei M; Hara K Nephrology (Carlton); 2018 Mar; 23(3):226-230. PubMed ID: 28052525 [TBL] [Abstract][Full Text] [Related]
27. Effect of lanthanum carbonate on serum calciprotein particles in patients with stage 3-4 CKD-results from a placebo-controlled randomized trial. Tiong MK; Smith ER; Pascoe EM; Elder GJ; Lioufas NM; Pedagogos E; Hawley CM; Valks A; Holt SG; Hewitson TD; Toussaint ND Nephrol Dial Transplant; 2023 Feb; 38(2):344-351. PubMed ID: 35212735 [TBL] [Abstract][Full Text] [Related]
28. Magnesium - its role in CKD. M de Francisco AL; Rodríguez M Nefrologia; 2013; 33(3):389-99. PubMed ID: 23640095 [TBL] [Abstract][Full Text] [Related]
29. The effects for inflammatory responses by CPP with different colloidal properties in hemodialysis patients. Mukai H; Miura Y; Kotani K; Kotoda A; Kurosu H; Yamada T; Kuro-O M; Iwazu Y Sci Rep; 2022 Dec; 12(1):21856. PubMed ID: 36528732 [TBL] [Abstract][Full Text] [Related]
30. Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphosphatemia. Yamada S; Tokumoto M; Tsuruya K; Tatsumoto N; Noguchi H; Kitazono T; Ooboshi H Am J Physiol Renal Physiol; 2015 Oct; 309(8):F744-54. PubMed ID: 26180236 [TBL] [Abstract][Full Text] [Related]
31. Magnesium as a new player in CKD: too little is as bad as too much? Hamano N; Komaba H; Fukagawa M Kidney Int; 2017 Nov; 92(5):1034-1036. PubMed ID: 29055421 [TBL] [Abstract][Full Text] [Related]
32. The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial. Bressendorff I; Hansen D; Pasch A; Holt SG; Schou M; Brandi L; Smith ER Nephrol Dial Transplant; 2021 Mar; 36(4):713-721. PubMed ID: 31764984 [TBL] [Abstract][Full Text] [Related]
33. The influence of phosphate, calcium and magnesium on matrix Gla-protein and vascular calcification: a systematic review. Houben E; Neradova A; Schurgers LJ; Vervloet M G Ital Nefrol; 2016; 33(6):. PubMed ID: 28134400 [TBL] [Abstract][Full Text] [Related]
34. Secondary calciprotein particle size is associated with patient mortality in peripheral artery disease. Bojic M; Cejka D; Bielesz B; Schernthaner GH; Höbaus C Atherosclerosis; 2023 Apr; 370():12-17. PubMed ID: 36898866 [TBL] [Abstract][Full Text] [Related]
35. Biochemical transformation of calciprotein particles in uraemia. Smith ER; Hewitson TD; Hanssen E; Holt SG Bone; 2018 May; 110():355-367. PubMed ID: 29499417 [TBL] [Abstract][Full Text] [Related]
36. Calciprotein Particles and Serum Calcification Propensity: Hallmarks of Vascular Calcifications in Patients with Chronic Kidney Disease. Silaghi CN; Ilyés T; Van Ballegooijen AJ; Crăciun AM J Clin Med; 2020 Apr; 9(5):. PubMed ID: 32365608 [TBL] [Abstract][Full Text] [Related]
37. Magnesium and Vascular Calcification in Chronic Kidney Disease: Current Insights. Zaslow SJ; Oliveira-Paula GH; Chen W Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256228 [TBL] [Abstract][Full Text] [Related]
38. Cellular Clearance and Biological Activity of Calciprotein Particles Depend on Their Maturation State and Crystallinity. Köppert S; Büscher A; Babler A; Ghallab A; Buhl EM; Latz E; Hengstler JG; Smith ER; Jahnen-Dechent W Front Immunol; 2018; 9():1991. PubMed ID: 30233585 [No Abstract] [Full Text] [Related]
39. Nanoparticle-based test measures overall propensity for calcification in serum. Pasch A; Farese S; Gräber S; Wald J; Richtering W; Floege J; Jahnen-Dechent W J Am Soc Nephrol; 2012 Oct; 23(10):1744-52. PubMed ID: 22956818 [TBL] [Abstract][Full Text] [Related]
40. Bisphosphonate FYB-931 Prevents High Phosphate-Induced Vascular Calcification in Rat Aortic Rings by Altering the Dynamics of the Transformation of Calciprotein Particles. Kawakami K; Ohya M; Yashiro M; Sonou T; Yamamoto S; Nakashima Y; Yano T; Tanaka Y; Ishida K; Kobashi S; Shigematsu T; Araki SI Calcif Tissue Int; 2023 Aug; 113(2):216-228. PubMed ID: 37099142 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]